| Dr Lori D Lerner, DO | |
|
339 W Main St, Avon, CT 06001-4322 | |
| (860) 696-2150 | |
| Not Available |
| Full Name | Dr Lori D Lerner |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 339 W Main St, Avon, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861788648 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 125060231 (Illinois) | Secondary |
| 207Q00000X | Family Medicine | 054845 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hartford Hospital | Hartford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Medical Group Inc | 1153573902 | 221 |
News Archive
2-phase randomized crossover study on a constant diet with calcium carbonate supplementation at 250 mg 4 times daily.
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.
Every 30 seconds, across the globe an individual loses a limb due to poor diabetes management. In the U.S., diabetes affects nearly 24 million people. When poorly controlled, diabetes results in nerve damage and poor circulation to the legs and feet.
Optimer Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010. Optimer reported a net loss for the third quarter of 2010 of $11.8 million, or $0.30 per share, which was in line with the Company's expectations. This compares to a net loss for the third quarter of 2009 of $9.4 million, or $0.28 per share. The increase in net loss was primarily due to an increase in research and development and marketing expenses.
› Verified 6 days ago
| Entity Name | Hartford Healthcare Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043561301 PECOS PAC ID: 1153573902 Enrollment ID: O20121201000007 |
News Archive
2-phase randomized crossover study on a constant diet with calcium carbonate supplementation at 250 mg 4 times daily.
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.
Every 30 seconds, across the globe an individual loses a limb due to poor diabetes management. In the U.S., diabetes affects nearly 24 million people. When poorly controlled, diabetes results in nerve damage and poor circulation to the legs and feet.
Optimer Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010. Optimer reported a net loss for the third quarter of 2010 of $11.8 million, or $0.30 per share, which was in line with the Company's expectations. This compares to a net loss for the third quarter of 2009 of $9.4 million, or $0.28 per share. The increase in net loss was primarily due to an increase in research and development and marketing expenses.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lori D Lerner, DO 1290 Silas Deane Hwy 2nd Floor, Wethersfield, CT 06109-4337 Ph: (860) 696-2150 | Dr Lori D Lerner, DO 339 W Main St, Avon, CT 06001-4322 Ph: (860) 696-2150 |
News Archive
2-phase randomized crossover study on a constant diet with calcium carbonate supplementation at 250 mg 4 times daily.
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.
Every 30 seconds, across the globe an individual loses a limb due to poor diabetes management. In the U.S., diabetes affects nearly 24 million people. When poorly controlled, diabetes results in nerve damage and poor circulation to the legs and feet.
Optimer Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010. Optimer reported a net loss for the third quarter of 2010 of $11.8 million, or $0.30 per share, which was in line with the Company's expectations. This compares to a net loss for the third quarter of 2009 of $9.4 million, or $0.28 per share. The increase in net loss was primarily due to an increase in research and development and marketing expenses.
› Verified 6 days ago
Dr. Robert A Rothenberg, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 21 Arts Center Court, Avon, CT 06001 Phone: 860-674-9686 Fax: 860-674-9954 | |
Dr. Spencer G Erman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 339 W Main St, Hartford Medical Group, Avon, CT 06001 Phone: 860-696-2150 Fax: 860-696-2160 | |
Alina Ileana Dobrita, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 W Avon Rd, Ste 301, Avon, CT 06001 Phone: 860-404-2905 Fax: 860-470-3198 | |
Dr. Marcin Jaremko, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 339 W Main St, Avon, CT 06001 Phone: 860-696-2150 Fax: 860-695-2160 | |
Dr. Anthony Roselli, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 54 W Avon Rd, Suite 101, Avon, CT 06001 Phone: 860-673-4534 Fax: 860-675-8798 | |
Richard Salmon, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5 Hawks Rdg, Avon, CT 06001 Phone: 860-810-5468 | |
Eric Walsh Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 385 W Main St, Avon, CT 06001 Phone: 860-777-1280 |